Effect of zoledronic acid (Z) treatment based on serum parathyroid hormone (PTH) levels in patients (pts) with malignant bone disease. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Berruti, A
  • Dogliotti, L
  • Tampellini, M
  • Lipton, A
  • Hirsh, V
  • Saad, F
  • Liati, P
  • shirina, N
  • Cook, Richard
  • Hei, YL

publication date

  • June 20, 2006